Back Stocks profile

Stock analysis tool for investors

Aarti Pharmalabs Ltd.

NSE: AARTIPHARM | BSE:543748

₹621.10 -1.50 (-0.24%) 1D

Pharmaceuticals & Biotechnology

View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

617.10

Today’s High

625.00

52W low

320.30

52W High

662.80

Open Price

623.80

Prev. Close

587.7500

Volume

44197.00

Value

27450756.70

Fundamentals

Market Cap Cr

5628.80

Price to Earnings

26.00

Price to Book Value

3.20

Dividend Yield

0.30

PE to Growth

-1.00

Op Revenue TTM Cr

1852.62

Net Profit TTM Cr

216.90

Cash From Operating Activity Cr

216.36

Return on Equity %

12.34

EMA & SMA

Bullish Moving Averages

11

Bearish Moving Averages

5

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

03 Jul, 2024

56

Week

52.4

Month

48

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

631.53

PIVOT

First Resistance

644.07

Second Resistance

665.53

Third Resistance

678.07

First Support

610.07

Second Support

597.53

Third Support

576.07

Relative Strength Index

54.88

Money Flow Index

66.02

MACD

15.66

MACD Signal

17.28

Average True Range

25.56

Average Directional Index

16.57

Rate of Change (21)

8.19

Rate of Change (125)

23.2

Commodity Channel Index

61

Williams %R

-56.6

BETA

1 Month

1.08

3 Month

1.07

1 Year

0.94

3 Year

PRICE CHANGE ANALYSIS

-0.56%

1 Week

Low

High

603.45

662.8

7.93%

1 Month

Low

High

497.05

662.8

37.44%

3 Months

Low

High

430

662.8

25.37%

6 Months

Low

High

399.55

662.8

69.24%

1 Year

Low

High

320.3

662.8

Bigul
26 Jun 2024

Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Credit Rating

Reaffirmation of Credit Rating for long-term bank loan facilities
Bigul
26 Jun 2024

Aarti Pharmalabs Ltd - 543748 - Closure of Trading Window

Intimation of Closure of Trading Window
Bigul
31 May 2024

Aarti Pharmalabs Ltd - 543748 - Announcement Under Regulation 30 Of SEBI LODR, 2015

Closure of manufacturing activities at the Company''s Dombivli Plant
Bigul
23 May 2024

Aarti Pharmalabs Ltd - 543748 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report for the Financial Year ended March 31, 2024
Bigul
15 May 2024

Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Recording of the Earnings Conference Call for Q4 FY 24/ FY 24
Bigul
15 May 2024

Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication of Audited Financial Results for the Quarter and Year ended March 31, 2024
Bigul
13 May 2024

Aarti Pharmalabs Ltd - 543748 - Appointment Of Auditors

Appointment of Auditors
Bigul
13 May 2024

Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Change in Directorate

Appointment of Smt. Nehal Garewal as Non-Executive Non-Independent Director of the Company
See all News

FAQs

The latest market price of Aarti Pharmalabs Ltd. on NSE was Rs. 621.10 as of today.

The opening share price of Aarti Pharmalabs Ltd. was Rs. 623.80 as of today.

The 52-week high share price of Aarti Pharmalabs Ltd. was Rs. 662.80.

The 52 week low share price of Aarti Pharmalabs Ltd. was Rs. 320.30.

Aarti Pharmalabs Ltd. has a market cap of Rs. 5628.80 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Aarti Pharmalabs Ltd. is -1.00. Please refer to the Fundamentals section for further details.

The operating revenue for Aarti Pharmalabs Ltd. in the last FY was Rs.  1852.62 crore. Please refer to the Financials section for further details.

The Net Profit for Aarti Pharmalabs Ltd. in the last FY was Rs. 216.90 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Aarti Pharmalabs Ltd. was on 2024-02-16 for Rs. 2 per share. According to today’s share price, the dividend yield of Aarti Pharmalabs Ltd. stands at 0.30. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Aarti Pharmalabs Ltd..

Close

Let's Open Free Demat Account